ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronEye IconIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintSite TitleTitle ChevronIcon Twitter
Retail Trade

COSMOS Pharmaceutical Corp.

Business Summary

COSMOS Pharmaceutical Corp. engages in the operation of drugstores. It operates through the following business divisions: Pharmaceutical, Cosmetics, Miscellaneous Goods, General Food, and Others. The Pharmaceutical division markets general drugs, health drinks, oral and nursing care products, vitamins, health food, and dietary food and supplements. The Cosmetics division engages in the sale of skin and hair care products for men and women; and makeup kits. The Miscellaneous Goods division sells detergents, insecticides, toiletries, kitchenware, garden supplies, clothing, and car related products. The General Food division includes processed food, seasonings, bread, pastries, dairy products, beverages, and liquor. The Others division distributes tobacco and cigarettes. The company was founded by Masateru Uno and Noriko Uno in February 1973 and is headquartered in Fukuoka, Japan.

Financial Highlights

May 2020 JPYUSD
Revenue684,403M6,326.77M
Gross Profit134,984M1,247.82M
Operating income29,094M268.95M
Income before tax30,402M281.04M
Net income21,435M198.14M
EBITDA42,656M394.32M
Diluted EPS541.295.00
Dividends Per Share550.50
Total Assets320,283M2,972.87M
Total liabilities174,605M1,620.68M
Total equity145,675M1,352.16M
Operating cash flow65,461M605.13M
Currency in JPYCurrency in USD

Historical Data

 May 2016May 2017May 2018May 2019May 2020
Revenue 447,273M 502,732M 557,999M 611,137M 684,403M
Gross Profit 78,090M 90,335M 99,430M 109,826M 134,984M
Operating income 18,648M 22,238M 22,750M 24,776M 29,094M
Income before tax 20,496M 25,737M 25,167M 27,139M 30,402M
Net income 12,435M 18,215M 17,633M 19,185M 21,435M
EBITDA 28,236M 32,948M 34,635M 37,734M 42,656M
Diluted EPS 314.02 459.98 445.28 484.48 541.29
Dividends Per Share 32.50 40 45 50 55
Total Assets 202,595M 225,691M 251,189M 274,085M 320,283M
Total liabilities 126,416M 132,636M 142,298M 147,794M 174,605M
Total equity 76,179M 93,053M 108,888M 126,289M 145,675M
Operating cash flow 30,986M 36,938M 32,586M 34,379M 65,461M
 May 2016May 2017May 2018May 2019May 2020
Revenue 3,781.66M 4,628.65M 5,054.19M 5,493.84M 6,326.77M
Gross Profit 660.24M 831.71M 900.60M 987.28M 1,247.82M
Operating income 157.66M 204.74M 206.06M 222.72M 268.95M
Income before tax 173.29M 236.96M 227.95M 243.96M 281.04M
Net income 105.13M 167.70M 159.71M 172.46M 198.14M
EBITDA 238.73M 303.35M 313.71M 339.21M 394.32M
Diluted EPS 2.65 4.23 4.03 4.35 5.00
Dividends Per Share 0.27 0.36 0.40 0.44 0.50
Total Assets 1,826.74M 2,040.88M 2,312.01M 2,524.38M 2,972.87M
Total liabilities 1,139.85M 1,199.40M 1,309.75M 1,361.21M 1,620.68M
Total equity 686.88M 841.46M 1,002.23M 1,163.14M 1,352.16M
Operating cash flow 261.98M 340.08M 295.15M 309.05M 605.13M

Valuation Measures

May 2020
PER28.57
ROA7.21%
ROE15.76%
Operating margin4.25%
Profit margin3.13%

Key executives

  • President & Representative Director: Hideaki Yokoyama
  • Director & Manager-Information Systems: Masahiro Iwashita
  • Director & Manager-Sales Planning: Motoi Takemori
  • Director & Manager-Corporate Planning: Futoshi Shibata
  • Director & Manager-Product Development: Yukitaka Uno

Shareholders

  • UNO FAMILY (38.2%)
  • Fidelity Management & Research Co. LLC (6.4%)
  • Yokeikai Foundation (3.7%)
  • Capital International KK (3.2%)
  • UNO YUKITAKA (2.9%)
  • UNO FUMIYASU (2.5%)
  • UNO MARIKO (2.5%)
  • Rheos Capital Works, Inc. (Investment Management) (2.0%)
  • Nomura Asset Management Co., Ltd. (1.5%)
  • JPMorgan Asset Management (Japan) Ltd. (1.4%)

Contact Details

  • Website:http://www.cosmospc.co.jp
  • Address: Daiichi Fukuoka Building S-Wing, 4/F, 2-10-1 Hakataeki-Higashi, Fukuoka, 812-0013, Japan
  • Phone: +81.92.433.0660

Related Companies

  • Green Flash KK
  • Cosmos Corp. KK
  • Cosmos Pharmaceutical Employee Stock Ownership Plan

Competitors

  • cocokara fine Inc.
Last Updated on 13 Aug, 2020

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Try 1 month for $0.99

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends July 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to the Nikkei Asian Review has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media